Cabot Corporation (CBT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Cabot Corporation stock (CBT) is currently trading at $70.71. Cabot Corporation PE ratio is 11.86. Cabot Corporation PS ratio (Price-to-Sales) is 0.98. Analyst consensus price target for CBT is $77.80. WallStSmart rates CBT as Hold.
- CBT PE ratio analysis and historical PE chart
- CBT PS ratio (Price-to-Sales) history and trend
- CBT intrinsic value — DCF, Graham Number, EPV models
- CBT stock price prediction 2025 2026 2027 2028 2029 2030
- CBT fair value vs current price
- CBT insider transactions and insider buying
- Is CBT undervalued or overvalued?
- Cabot Corporation financial analysis — revenue, earnings, cash flow
- CBT Piotroski F-Score and Altman Z-Score
- CBT analyst price target and Smart Rating
Cabot Corporation
📊 No data available
Try selecting a different time range
CBT Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Cabot Corporation (CBT)
CBT trades 95% above its Graham fair value of $38.90, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Cabot Corporation (CBT) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, return on equity, price/sales. Concerns around revenue growth and eps growth. Fundamentals are solid but monitor weak areas for improvement.
Cabot Corporation (CBT) Key Strengths (5)
Paying less than $1 for every $1 of annual revenue
101.35% of shares held by major funds and institutions
Every $100 of equity generates $22 in profit
Good growth relative to its price
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Cabot Corporation (CBT) Areas to Watch (5)
Revenue declining -11.10%, a shrinking business
Earnings declining -18.20%, profits shrinking
Thin profit margins with limited profitability
Decent operational efficiency, solid but not exceptional
Fairly priced relative to book value
Cabot Corporation (CBT) Detailed Analysis Report
Overall Assessment
This company scores 60/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.8/10) while 5 fall into concern territory (avg 3.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Institutional Own., Return on Equity. Valuation metrics including PEG Ratio (1.00), Price/Sales (0.98) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 21.80%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Profit Margin. Some valuation metrics including Price/Book (2.25) suggest expensive pricing. Growth concerns include Revenue Growth at -11.10%, EPS Growth at -18.20%, which may limit upside. Profitability pressure is visible in Operating Margin at 15.20%, Profit Margin at 8.62%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 21.80% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -11.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Institutional Own.) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CBT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CBT's Price-to-Sales ratio of 0.98x trades at a 29% premium to its historical average of 0.76x (80th percentile). The current valuation is 26% below its historical high of 1.32x set in Jan 2018, and 478% above its historical low of 0.17x in Feb 2009. Over the past 12 months, the PS ratio has compressed from ~1.1x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Cabot Corporation (CBT) · BASIC MATERIALS › SPECIALTY CHEMICALS
The Big Picture
Cabot Corporation operates as a stable business with moderate growth and solid fundamentals. Revenue reached 3.6B with 11% decline year-over-year. Profit margins are thin at 8.6%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 2180.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 57M in free cash flow and 126M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 11% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Cabot Corporation push profit margins above 15% as the business scales?
Dividend sustainability with a current yield of 260.0%. Watch payout ratio and free cash flow coverage.
Debt management: total debt of 1.1B is significantly higher than cash (230M). Monitor refinancing risk.
Sector dynamics: monitor SPECIALTY CHEMICALS industry trends, competitive moves, and regulatory changes that could impact Cabot Corporation.
Bottom Line
Cabot Corporation offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(25 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:24:17 AM
About Cabot Corporation(CBT)
NYSE
BASIC MATERIALS
SPECIALTY CHEMICALS
USA
Cabot Corporation (CBT) is a premier global specialty chemicals and performance materials company, recognized for its innovative solutions that elevate performance, sustainability, and safety in diverse applications across industries such as tire, plastics, coatings, and electronics. The company specializes in carbon black, recovery solutions, and specialty compounds, underpinned by strong research and development capabilities that foster continuous innovation. With a commitment to operational excellence and environmental sustainability, Cabot Corporation seeks to minimize its ecological footprint while maximizing performance outcomes, reinforcing its status as a trusted partner in advanced materials and a leader in sustainable practices.